Preliminary probe shows cancer patient received appropriate treatment, says health body
The National Health Commission said on Tuesday that the allegedly expensive and unnecessary treatment provided to a cancer patient from Qinghai is believed to have complied with relevant medical standards and regulations.
Whether the doctor in Shanghai treating the patient had gained illegal benefits by putting the patient through some costly treatment procedures, including NeuroKinetic therapy and genetic testing, was still under investigation, Jiao Yahui, director of the commission's medical supervision and administration bureau, said during a news conference.
In a recent online post, an oncologist from Peking University Third Hospital accused some doctors of malpractice, deliberately choosing substandard or expensive treatment options out of personal interest.
The commission said on April 19 that it had launched an investigation into the allegation.
On Tuesday, Jiao said the commission has required health authorities in Shanghai to further probe into the case involving the patient from Qinghai.
"If illegal exchanges of benefits or propping are found, we will not cover up or turn a blind eye to them. We will handle them severely according to laws and regulations," she said.
- Gansu official at center of anti-graft probe turns himself in
- Chinese and Egyptian air forces to hold training exercise
- China releases its first comprehensive report on ecosystem status of the Xisha, Zhongsha, and Nansha Islands and reefs
- China's environmental inspections body charts progress
- DPP creating war panic on Taiwan: defense ministry
- China issues flood warning in aftermath of Typhoon Dolphin






























